Daniel Gallego-Perez
Associate Professor and Edgar C. Hendrickson Designated Chair, Department of Biomedical Engineering
College of Engineering
Associate Professor, Department of Surgery
College of Medicine
Director of the Center for Advanced Nanotherapeutics, Gene Therapy Institute
Daniel Gallego-Perez’s research focuses on developing nanotechnology-driven platforms for fundamental and translational biomedical research. Much of his research has been devoted to using nanotechnology to induce controlled lineage conversions in vivo as a potential therapeutic approach for different conditions. Gallego-Perez currently supervises multiple projects testing this approach within the context of diabetes, peripheral nerve injury, chronic brain injury, Alzheimer’s disease and related dementias, and cancer. He is the lead inventor of the Tissue Nano-Transfection (TNT) technology, for which he was awarded the National Institutes of Health Director’s New Innovator Award to work on developing TNT-driven therapies for ischemic stroke and peripheral nerve injury. He was elected a Fellow of the American Institute for Medical and Biological Engineering for outstanding contributions to the development of nanotechnology-based platforms for non-viral gene delivery, tissue reprogramming, regenerative medicine and cancer therapies.
Joshua J. Joseph
Associate Professor, Endowed Professor for Research in Internal Medicine, Department of Internal Medicine
College of Medicine
Joshua J. Joseph is founder and medical director for The Ohio State University Wexner Medical Center Healthy Community Center, which offers nutrition and wellness to Columbus’ Near East Side residents. Internationally recognized for his work on academic, community, government and industry partnerships to advance health through community-based interventions, Joseph’s research focuses on advancing the prevention and treatment of obesity, diabetes and cardiovascular disease through a health-equity lens. His research focuses on four pillars: examining the role of stress hormones in cardiometabolic disease, health system-to-community partnerships, community-based participatory research, and quality improvement science. His ACCELERATE research group’s work has been featured in multiple national and international media outlets.
Brian J. Skinner
Assistant Professor, Department of Physics
College of Arts and Sciences
Brian J. Skinner performs theoretical research into the nature and dynamics of quantum entanglement and the quantum mechanical behavior of materials. He is a principal investigator in Ohio State’s Center for Emergent Materials, which is a National Science Foundation(NSF) Materials Research Science and Engineering Center, a member of the Center for Quantum Information Science and Engineering and a core faculty member of the Translational Data Analytics Institute. In 2023, he received the inaugural Frontiers in Science Award, an international honor that recognized just five condensed matter physics works deemed to be the most impactful during the past five years. In 2021, he was awarded an NSF CAREER Award for his research on quantum materials.
Jiangjiang (Chris) Zhu
Associate Professor, Department of Human Sciences
College of Education and Human Ecology
Molecular Carcinogenesis and Chemoprevention Program
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Jiangjiang (Chris) Zhu’s research investigates the development and application of mass spectrometry-based metabolomics, human microbial metabolic analysis for the understanding of human-microbe interaction, nutritional metabolomics studies and cancer metabolism studies. His current research includes studying host-microbiota metabolic interactions and the critical roles of nutritional components in modulating such interactions and investigating the impact of therapeutic modulation of gut microbes on colorectal cancer patients. He is also developing a multiplex mass spectrometry-based metabolomics platform for cancer diagnosis and treatment monitoring. In addition to holding a patent for biomarkers for detecting and monitoring colon cancer, Zhu has co-authored several dozen articles in the field’s most respected publications.
